|Day Low/High||389.95 / 404.07|
|52 Wk Low/High||196.78 / 404.20|
Take advantage of elevated option premiums to gain long exposure to biotech.
DNA sequencing company Illumina (ILMN) plummeted in midday trading Tuesday after reporting disappointing preliminary sales for its third quarter.
With such a commanding lead in the sequencing business the stock can't stay down for long.
Apple (AAPL) and Microsoft (MSFT) dragged on benchmark indexes.
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
After a strong run for the maker of scientific tools, investors may be vulnerable to a correction.
It's almost impossible to get too excited about its success.
Sector may not be as bulletproof as we thought.
Washington will offer mixed bag answers to key policy questions.